Stockscreener 앱 받기
76.71
2.70%
-2.13
Globus Medical Inc 주식(GMED)의 최신 뉴스
GMED or AXGN: Which Is the Better Value Stock Right Now? - Zacks Investment Research
Reasons to Add STE Stock to Your Portfolio Right Now - Zacks Investment Research
Haemonetics Gains 149.3% in a Year: What's Driving the Rally? - Zacks Investment Research
Is it Apt to Retain Medtronic Stock in Your Portfolio Now? - Zacks Investment Research
Is Spine Tech Unveiling Altering The Investment Case For Globus Medical Stock? - Yahoo Finance
RBC cuts target to USD 85.00 for Globus Medical stock - ad-hoc-news.de
BD's Revello Stent Shows Strong AGILITY Trial Results for PAD Patients - Zacks Investment Research
Doximity Deepens U.S. News Alliance to Improve Patient Access to Care - Zacks Investment Research
Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now? - Zacks Investment Research
Is Globus Medical (GMED) Cheap On Its Spine Platform Reveal? - Yahoo Finance
What Does Globus Medical (GMED) Mean For Spine Care After Its NASS 2026 Reveal? - Yahoo Finance
Globus Medical (GMED) Stock Looks Discounted Against Its Earnings Outlook - Yahoo Finance
Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026 - Orthopedics This Week
Glaukos Stock Gains 36.8% in 6 Months: What's Behind the Rally? - Zacks Investment Research
Globus Medical, Inc. (GMED.MX) stock price, news, quote and history - Yahoo Finance UK
BTSG Stock Climbs 67.3% YTD: What's Driving the Rally in 2026? - Zacks Investment Research
Reasons to Add QuidelOrtho Stock to Your Portfolio for Now - Zacks Investment Research
Hims & Hers Expands Australian Women's Health Platform With Hers - Zacks Investment Research
A new platform is designed to let surgeons tailor spinal implants to each patient. Globus Medical will preview it at NASS. - Stock Titan
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now - Zacks Investment Research
ISRG Is Expanding Beyond Surgery: Here's Why the GI Opportunity Matters - Zacks Investment Research
Here's Why You Should Add Avantor Stock to Your Portfolio for Now - Zacks Investment Research
Veeva Systems' Basics Gains Traction With 175+ Emerging Biotech Firms - Zacks Investment Research
Globus Medical to Announce Third Quarter 2026 Financial Results on November 5 and Hold Conference Call - Quiver Quantitative
Globus Medical Schedules Third Quarter Earnings Release and Conference Call - GlobeNewswire
Here's Why You Should Retain AMN Stock in Your Portfolio for Now - Zacks Investment Research
Globus Medical Q2 2026 Earnings Call Transcript - Benzinga
How Globus Medical Inc. Class A (GMED) Affects Rotational Strategy Timing - Stock Traders Daily
ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/Y - Zacks Investment Research
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now - Zacks Investment Research
Is it the Right Time to Hold TNDM Stock in Your Portfolio? - Zacks Investment Research
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - Zacks Investment Research
Globus Medical, Inc. (GMED) Stock Forecasts - Yahoo Finance
Globus Medical, Inc. (GMED) Stock forecasts - Yahoo Finance Singapore
RBC cuts target for Globus Medical stock to USD 85.00 - AD HOC NEWS
Is it the Right Time to Add Phibro Stock to Your Portfolio? - Zacks Investment Research
Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets - Zacks Investment Research
Reasons to Retain Hims & Hers Stock in Your Portfolio for Now - Zacks Investment Research
Should Globus Medical's Expanding Musculoskeletal Pipeline and Cash-Funded Growth Strategy Matter to GMED Investors? - Yahoo! Finance Canada
Should Globus Medical's Expanding Musculoskeletal Pipeline and Cash-Funded Growth Strategy Matter to GMED Investors? - Yahoo Finance
10x Genomics & Fred Hutch Join Forces on Cancer Biomarker Research - Zacks Investment Research
Here's Why You Should Retain WAT Stock in Your Portfolio for Now - Zacks Investment Research
Globus Medical (GMED) Stock Sees Modest Fair Value Cut As Analysts Split On Outlook - Yahoo Finance
Globus Medical, Inc. (GMED) Stock Forecasts - Yahoo Finance
Globus Medical stock faces a new Hold view at USD 73.90 - AD HOC NEWS
A Look at Globus Medical Inc (GMED) After 3.5% Decline -- GF Val - GuruFocus
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now - Zacks Investment Research
BDX Expands U.S. Manufacturing With $19B Healthcare Investment - Zacks Investment Research
Reasons to Hold HealthEquity Stock in Your Portfolio for Now - Zacks Investment Research
Veeva's DQS Scales Data Automation Across 1,000+ Clinical Studies - Zacks Investment Research
1.68%
0.25%
자본화:
|
볼륨(24시간):